Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Revenus
2,227
2,227
2,066
2,089
1,902
1,646
Croissance des revenus (H/H)
8%
8%
-1%
10%
16%
23%
Coût des ventes
1,052
1,052
977
883
775
679
Bénéfice brut
1,175
1,175
1,088
1,205
1,127
967
Vente, Général et Administration
626
626
569
504
438
363
Recherche et développement
326
326
343
349
291
232
Frais d'exploitation
951
951
894
857
730
596
Autres revenus (charges) non opérationnels
1
1
44
14
51
-2
Bénéfice avant impôts
193
193
240
412
403
339
Charge d'impôt sur le revenu
51
51
60
120
107
101
Bénéfice net
141
141
178
290
293
236
Croissance du bénéfice net
-21%
-21%
-39%
-1%
24%
93%
Actions en circulation (diluées)
87.2
87.53
88.85
89.44
89.44
89.44
Variation des actions (H-H)
0%
-1%
-1%
0%
0%
0%
EPS (dilué)
1.61
1.61
2.01
3.25
3.29
2.64
Croissance du EPS
-21%
-20%
-38%
-1%
25%
93%
Flux de trésorerie libre
133
133
95
137
106
296
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
52.76%
52.76%
52.66%
57.68%
59.25%
58.74%
Marge opérationnelle
10.01%
10.01%
9.39%
16.65%
20.82%
22.53%
Marge bénéficiaire
6.33%
6.33%
8.61%
13.88%
15.4%
14.33%
Marge du flux de trésorerie libre
5.97%
5.97%
4.59%
6.55%
5.57%
17.98%
EBITDA
349
349
326
422
465
432
Marge EBITDA
15.67%
15.67%
15.77%
20.2%
24.44%
26.24%
D&A pour le résultat opérationnel
126
126
132
74
69
61
EBIT
223
223
194
348
396
371
Marge EBIT
10.01%
10.01%
9.39%
16.65%
20.82%
22.53%
Taux d'imposition effectif
26.42%
26.42%
25%
29.12%
26.55%
29.79%
Statistiques clés
Clôture préc.
$34.66
Prix d'ouverture
$31.97
Plage de la journée
$31.63 - $32.51
Plage de 52 semaines
$32.51 - $70.88
Volume
13
Volume moyen
95
BPA (TTM)
1.94
Rendement en dividend
--
Capitalisation boursière
$2.8B
Qu’est-ce que Carl Zeiss Meditec AG ?
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.